Case Report: Successful treatment of verruciform acanthotic vulvar intraepithelial neoplasia with 5-aminolevulinic acid photodynamic therapy.

IF 3.6 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL
Frontiers in Medicine Pub Date : 2026-10-07 eCollection Date: 2026-01-01 DOI:10.3389/fmed.2026.1949400
Yitao Qian, Wenjing Zha, Jie Shen, Ke Li, Szeman Cheung, Yiwu Yu, Jianhua Huang, Ting Lyu, Fei Miao, Hongwei Wang, Lei Shi
{"title":"Case Report: Successful treatment of verruciform acanthotic vulvar intraepithelial neoplasia with 5-aminolevulinic acid photodynamic therapy.","authors":"Yitao Qian, Wenjing Zha, Jie Shen, Ke Li, Szeman Cheung, Yiwu Yu, Jianhua Huang, Ting Lyu, Fei Miao, Hongwei Wang, Lei Shi","doi":"10.3389/fmed.2026.1949400","DOIUrl":null,"url":null,"abstract":"<p><p>Verruciform acanthotic vulvar intraepithelial neoplasia (vaVIN) is a rare, human papillomavirus (HPV)-independent, p53 wild-type intraepithelial precursor of the vulva, and standardized therapies for this disease are currently lacking. We report the case of a 68-year-old woman who presented with a 2-year history of multiple warty papules and vulvar pruritus and was diagnosed with vaVIN on the basis of histopathology (verruciform acanthosis with compact orthokeratosis, hypogranulosis, and superficial keratinocyte pallor with minimal cytologic atypia) and immunohistochemistry (HPV negativity, a p53 wild-type pattern, and non-block p16 expression) analyses. She underwent 5-aminolevulinic acid photodynamic therapy (ALA-PDT) and achieved complete clinical remission, with no recurrence during the follow-up period. To our knowledge, reports on the use of photodynamic therapy for vaVIN are scarce. This case suggests that ALA-PDT may be a promising alternative treatment option for vaVIN.</p>","PeriodicalId":12488,"journal":{"name":"Frontiers in Medicine","volume":"13 ","pages":"1949400"},"PeriodicalIF":3.6000,"publicationDate":"2026-10-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13683215/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3389/fmed.2026.1949400","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

Verruciform acanthotic vulvar intraepithelial neoplasia (vaVIN) is a rare, human papillomavirus (HPV)-independent, p53 wild-type intraepithelial precursor of the vulva, and standardized therapies for this disease are currently lacking. We report the case of a 68-year-old woman who presented with a 2-year history of multiple warty papules and vulvar pruritus and was diagnosed with vaVIN on the basis of histopathology (verruciform acanthosis with compact orthokeratosis, hypogranulosis, and superficial keratinocyte pallor with minimal cytologic atypia) and immunohistochemistry (HPV negativity, a p53 wild-type pattern, and non-block p16 expression) analyses. She underwent 5-aminolevulinic acid photodynamic therapy (ALA-PDT) and achieved complete clinical remission, with no recurrence during the follow-up period. To our knowledge, reports on the use of photodynamic therapy for vaVIN are scarce. This case suggests that ALA-PDT may be a promising alternative treatment option for vaVIN.

病例报告:5-氨基乙酰丙酸光动力治疗疣状棘皮外阴上皮内瘤变成功。
外阴疣状棘突上皮内瘤变(vaVIN)是一种罕见的、不依赖于人乳头瘤病毒(HPV)的p53野生型外阴上皮内前体,目前缺乏针对这种疾病的标准化治疗。我们报告一例68岁的女性,她有2年的多发疣状丘疹和外阴瘙痒史,并根据组织病理学(疣状棘皮病伴紧密形角化病、低颗粒病和浅表角化细胞苍白,细胞异型性最小)和免疫组织化学(HPV阴性、p53野生型和非阻断p16表达)分析诊断为vaVIN。患者接受5-氨基乙酰丙酸光动力治疗(ALA-PDT),临床完全缓解,随访期间无复发。据我们所知,关于使用光动力疗法治疗vaVIN的报道很少。本病例提示ALA-PDT可能是vaVIN的一种有希望的替代治疗方案。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Frontiers in Medicine
Frontiers in Medicine Medicine-General Medicine
CiteScore
5.10
自引率
5.10%
发文量
3710
审稿时长
12 weeks
期刊介绍: Frontiers in Medicine publishes rigorously peer-reviewed research linking basic research to clinical practice and patient care, as well as translating scientific advances into new therapies and diagnostic tools. Led by an outstanding Editorial Board of international experts, this multidisciplinary open-access journal is at the forefront of disseminating and communicating scientific knowledge and impactful discoveries to researchers, academics, clinicians and the public worldwide. In addition to papers that provide a link between basic research and clinical practice, a particular emphasis is given to studies that are directly relevant to patient care. In this spirit, the journal publishes the latest research results and medical knowledge that facilitate the translation of scientific advances into new therapies or diagnostic tools. The full listing of the Specialty Sections represented by Frontiers in Medicine is as listed below. As well as the established medical disciplines, Frontiers in Medicine is launching new sections that together will facilitate - the use of patient-reported outcomes under real world conditions - the exploitation of big data and the use of novel information and communication tools in the assessment of new medicines - the scientific bases for guidelines and decisions from regulatory authorities - access to medicinal products and medical devices worldwide - addressing the grand health challenges around the world
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书